These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Wilson C; Thakore A; Isenberg D; Ebringer A Rheumatol Int; 1997; 16(5):187-9. PubMed ID: 9032817 [TBL] [Abstract][Full Text] [Related]
26. An immunoprotective monoclonal antibody to lipopolysaccharide. Kirkland TN; Ziegler EJ J Immunol; 1984 May; 132(5):2590-2. PubMed ID: 6201551 [TBL] [Abstract][Full Text] [Related]
27. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Bahrani FK; Johnson DE; Robbins D; Mobley HL Infect Immun; 1991 Oct; 59(10):3574-80. PubMed ID: 1680106 [TBL] [Abstract][Full Text] [Related]
29. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis. Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574 [TBL] [Abstract][Full Text] [Related]
30. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. Zunino P; Geymonat L; Allen AG; Legnani-Fajardo C; Maskell DJ FEMS Immunol Med Microbiol; 2000 Oct; 29(2):137-43. PubMed ID: 11024353 [TBL] [Abstract][Full Text] [Related]
31. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis. Habibi M; Asadi Karam MR; Bouzari S APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627 [TBL] [Abstract][Full Text] [Related]
32. Structures of the O-specific polysaccharides and a serological cross-reactivity of the lipopolysaccharides of Proteus mirabilis O24 and O29. Literacka E; Perepelov AV; Senchenkova SN; Zatonsky GV; Shashkov AS; Knirel YA; Kaca W FEBS Lett; 1999 Aug; 456(2):227-31. PubMed ID: 10456314 [TBL] [Abstract][Full Text] [Related]
33. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection. Habibi M; Asadi Karam MR; Bouzari S Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195 [TBL] [Abstract][Full Text] [Related]
34. Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis. Legnani-Fajardo C; Zunino P; Algorta G; Laborde HF Can J Microbiol; 1991 Apr; 37(4):325-8. PubMed ID: 1680542 [TBL] [Abstract][Full Text] [Related]
35. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis. Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310 [TBL] [Abstract][Full Text] [Related]
36. Immunochemical characterization of the O antigens of two Proteus strains, O8-related antigen of Proteus mirabilis 12 B-r and O2-related antigen of Proteus genomospecies 5/6 12 B-k, infecting a hospitalized patient in Poland. Drzewiecka D; Shashkov AS; Arbatsky NP; Knirel YA Microbiology (Reading); 2016 May; 162(5):789-797. PubMed ID: 26959528 [TBL] [Abstract][Full Text] [Related]
37. O antigens of Proteus mirabilis and Proteus vulgaris strains isolated from patients with bacteremia. Larsson P J Clin Microbiol; 1980 Oct; 12(4):490-2. PubMed ID: 6999017 [TBL] [Abstract][Full Text] [Related]
38. Urinary tract infections caused by Proteus mirabilis in children. The antibody response to O and H antigens and Tamm-Horsfall protein and bacterial adherence to uro-epithelium. Larsson P; Fasth A; Jodal U; Akerlund AS; Edén CS Acta Paediatr Scand; 1978 Sep; 67(5):591-6. PubMed ID: 358736 [TBL] [Abstract][Full Text] [Related]